These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37653014)

  • 21. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.
    Zhao F; Zhou Y; Ge PF; Huang CJ; Yu Y; Li J; Sun YG; Meng YC; Xu JX; Jiang T; Zhang ZX; Sun JP; Wang W
    BMC Cancer; 2017 Apr; 17(1):267. PubMed ID: 28407802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.
    Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y
    Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Clinical and Pathological Features of Malignant Pulmonary Nodules.
    Wang Y; Huang Q; Li J
    Altern Ther Health Med; 2023 May; 29(4):188-193. PubMed ID: 36947653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
    Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
    J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical research on surgical treatment for non-small cell lung cancer of diameter less than 2 cm].
    Wei L; Zhao S; Chen MY; Chen Z; Chen X
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2502-4. PubMed ID: 24300276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node metastasis outside of a tumor-bearing lobe in primary lung cancer and the status of interlobar fissures: The necessity for removing lymph nodes from an adjacent lobe.
    Li H; Wang R; Zhang D; Zhang Y; Li W; Zhang B; Liu Q; Du J
    Medicine (Baltimore); 2019 Mar; 98(12):e14800. PubMed ID: 30896623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer.
    Kudo Y; Saji H; Shimada Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2012 Nov; 78(2):153-60. PubMed ID: 22944144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer.
    Ma K; Chang D; He B; Gong M; Tian F; Hu X; Ji Z; Wang T
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1289-95. PubMed ID: 18504610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node sampling in lung cancer: how should it be done?
    Naruke T; Tsuchiya R; Kondo H; Nakayama H; Asamura H
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S17-24. PubMed ID: 10536940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blind spot in lung cancer lymph node metastasis: Cross-lobe peripheral lymph node metastasis in early stage patients.
    Li N; Tan F; Li J; Shao K; Zhao J; Mu J; Gao S; He J
    Thorac Cancer; 2018 Apr; 9(4):480-485. PubMed ID: 29517861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation.
    Konaka C; Ikeda N; Hiyoshi T; Tsuji K; Hirano T; Kawate N; Ebihara Y; Kato H
    Lung Cancer; 1998 Sep; 21(3):185-91. PubMed ID: 9857996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correlation factors of lymph node metastasis in patients with clinical stage T1a non-small cell lung cancer].
    Ruochuan Z; Shugeng G; Jie H; Yousheng M; Qi X; Dali W; Juwei M; Jun Z; Yonggang W; Xiangyang L; Fengwei T; Gefei Z; Qian Z; Moyan Z; Peng S
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):297-300. PubMed ID: 26462896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection.
    Matsumura Y; Hishida T; Yoshida J; Aokage K; Ishii G; Nagai K
    J Thorac Oncol; 2012 Nov; 7(11):1691-7. PubMed ID: 23059781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm.
    Wo Y; Li H; Chen Z; Peng Y; Zhang Y; Ye T; Jiang W; Sun Y
    Clin Lung Cancer; 2023 Jul; 24(5):437-444. PubMed ID: 37029008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.